Novartis Investigative Site

McAllen, Texas 78503-1298

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Cardiovascular Disease, Neoplasms, Breast, Type 2 Diabetes Mellitus

Studies at this site

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early